Common Stock, Shares, Outstanding of Spyre Therapeutics, Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Spyre Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • Spyre Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 60,471,793, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 60,471,793 +9,076,185 +18% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 60,372,927 +9,589,543 +19% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 60,275,561 +23,645,881 +65% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 60,257,023 +24,199,914 +67% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 51,395,608 +47,346,921 +1169% 30 Sep 2024 10-Q/A 18 Nov 2024 2024 Q3
Q2 2024 50,783,384 -30,218,292 -37% 30 Jun 2024 10-Q/A 18 Nov 2024 2024 Q2
Q1 2024 36,629,680 -28,765,479 -44% 31 Mar 2024 10-Q/A 18 Nov 2024 2024 Q1
Q4 2023 36,057,109 +33,443,095 +1279% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 4,048,687 -57,462,391 -93% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 81,001,676 +19,829,166 +32% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 65,395,159 +15,975,286 +32% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 2,614,014 -46,741,116 -95% 31 Dec 2022 10-K/A 18 Nov 2024 2023 FY
Q3 2022 61,511,078 +12,204,971 +25% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 61,172,510 +12,146,554 +25% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 49,419,873 +399,972 +0.82% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 49,355,130 +1,396,044 +2.9% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 49,306,107 +4,614,077 +10% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 49,025,956 +4,426,109 +9.9% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 49,019,901 +19,872,440 +68% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 47,959,086 +18,874,649 +65% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 44,692,030 +15,768,789 +55% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 44,599,847 +15,751,544 +55% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 29,147,461 +310,109 +1.1% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 29,084,437 +4,944,340 +20% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 28,923,241 +6,825,023 +31% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 28,848,303 +6,940,111 +32% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 28,837,352 +12,027,683 +72% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 24,140,097 +7,469,909 +45% 31 Dec 2018 10-K 24 Feb 2020 2019 FY
Q3 2018 22,098,218 +5,625,387 +34% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 21,908,192 +5,455,932 +33% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 16,809,669 +3,357,409 +25% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 16,670,188 +3,239,355 +24% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 16,472,831 +3,041,998 +23% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 16,452,260 +3,040,488 +23% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 13,452,260 +12,694,924 +1676% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 13,430,833 +12,673,497 +1673% 31 Dec 2016 10-K 13 Mar 2018 2017 FY
Q3 2016 13,430,833 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 13,411,772 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 757,336 31 Mar 2016 10-Q 19 May 2016 2016 Q1
Q4 2015 757,336 31 Dec 2015 10-K 23 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.